ArticleHealth research policy and systems2021
Lessons from the pandemic on the value of research infrastructure.
Article in Health research policy and systems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- The Road from Science to Health: The Importance of Designing For, Measuring, and Communicating Impact in Public Health.Annual review of public health · 2026Review
- Have changes in practice in response to COVID-19 been sustained? A qualitative study of experiences and perceptions of health system stakeholders in Colombia.Health research policy and systems · 2026Article
- Redefining pandemic resilience: a roadmap for post-infectious syndrome preparedness and health system transformation.Frontiers in health services · 2026Article
- EuroQol data for assessment of population health needs and instrument evaluation (EQ-DAPHNIE): a study for enhancing population health assessment.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025Article
- Health research versus the virus: strengthening systems, saving lives.Health research policy and systems · 2025Article
- Building Resilient and Responsive Health Research Systems:Responses and the Lessons Learned from the COVID-19 Pandemic.Health research policy and systems · 2025Review
- Exploring views of South African research ethics committees on pandemic preparedness and response during COVID-19.Research ethics · 2024Article
- A research landscape bibliometric analysis on climate change for last decades: Evidence from applications of machine learning.Heliyon · 2023Article
- [Castellón Field Hospital: comprehensive analysis of its use during the SARS-CoV-2 pandemic.]Revista espanola de salud publica · 2023Observational
- Resilience in keeping the balance between demand and capacity in the COVID-19 pandemic, a case study at a Swedish middle-sized hospital.BMC health services research · 2023Article
- Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges.Health research policy and systems · 2022Article
- The organization and impacts of clinical research delivery workforce redeployment during the COVID-19 pandemic: a qualitative case study of one research-intensive acute hospital trust.Health research policy and systems · 2022Article
- The economic challenges of new drug development.Journal of controlled release : official journal of the Controlled Release Society · 2022Article
- Rapid research response to the COVID-19 pandemic: perspectives from a National Institute for Health Biomedical Research Centre.Health research policy and systems · 2022Article
- Pandemic preparedness and responsiveness of research review committees: lessons from review of COVID-19 protocols at KEMRI Wellcome Trust Research Programme in Kenya.Wellcome open research · 2022Article
- Impacts of COVID-19 on clinical research in the UK: A multi-method qualitative case study.PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The COVID-19 pandemic has shed a spotlight on the resilience of healthcare systems, and their ability to cope efficiently and effectively with unexpected crises. If we are to learn one economic lesson from the pandemic, arguably it is the perils of an overfocus on short-term allocative efficiency at the price of lack of capacity to deal with uncertain future challenges. In normal times, building spare capacity with 'option value' into health systems may seem inefficient, the costs potentially exceeding the benefits. Yet the fatal weakness of not doing so is that this can leave health systems highly constrained when dealing with unexpected, but ultimately inevitable, shocks-such as the COVID-19 pandemic. In this article, we argue that the pandemic has highlighted the potentially enormous option value of biomedical research infrastructure. We illustrate this with reference to COVID-19 response work supported by the United Kingdom National Institute for Health Research Oxford Biomedical Research Centre. As the world deals with the fallout from the most serious economic crisis since the Great Depression, pressure will soon come to review government expenditure, including research funding. Developing a framework to fully account for option value, and understanding the public appetite to pay for it, should allow us to be better prepared for the next emerging problem.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.